Clinical Benefit of a Combination of Ipilimumab and Nivolumab in Treatment-Naïve Patients with Advanced or Metastatic Non-Clear Cell RCC By Ogkologos - April 15, 2025 263 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SUNNIFORECAST study Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide in Testicular Cancer Now Available Also in Italian Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer MOST POPULAR Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ January 8, 2025 Opinion: ‘We’re speaking with One Cancer Voice, but is anyone listening?’ March 16, 2021 Preparación para el fin de la emergencia de salud pública (PHE)... April 3, 2023 A new approach to cancer immunotherapy March 18, 2022 Load more HOT NEWS Shorter, More Intensive Radiation Safe after Surgery for Prostate Cancer Clinical Trials in Genitourinary Cancers: KEYNOTE-641, P3BEP, and PIVOT-09 Sing Anyway Molecular Determinants of Sotorasib Efficacy in Patients with Advanced KRASG12C-mutated NSCLC
